Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5.43M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+512K
-
Total reported value, excl. options
-
$466M
-
Value change
-
+$17.9M
-
Number of buys
-
33
-
Number of sells
-
-14
-
Price
-
$34.76
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q1 2020
54 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q1 2020.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
.
Largest 10 shareholders include FMR LLC (3.03M shares), 5AM Venture Management, LLC (2.85M shares), Redmile Group, LLC (2.27M shares), Sectoral Asset Management Inc (1.47M shares), JANUS HENDERSON GROUP PLC (1.22M shares), Rock Springs Capital Management LP (500K shares), BlackRock Inc. (356K shares), CITADEL ADVISORS LLC (321K shares), VANGUARD GROUP INC (268K shares), and Artisan Partners Limited Partnership (229K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.